Goal of D1 Sample Clauses

Goal of D1. 1 Deliverable D1.1 “epSOS identification/description problems” has the goal to collect and document the issues and gaps encountered in the univocal identification of medicinal products noted in an ePrescription from another country by the Participation Nations when piloting the epSOS ePrescription cross-border services, together with the improvements already identified in other projects like EXPAND. Chapter 2 summarises the ePrescription / eDispensation Use Cases, as defined in epSOS. Chapter 3 reports about issues encountered during epSOS pilot. The encountered limitations may be classified as:  Non availability of structured coded medicinal product related data in the country where the prescription is issued 8 EC ICT PSP Thematic Network EXPAND: Expanding Health Data Interoperability Services, Grant Agreement n. 620980  Problems in describing complex medicinal products, by using the defined ePrescription structure, syntax and adopted code systems / Value Sets, in the country where the prescription is issued  Problems of mapping coded data in the country of origin with the selected Value Set, in order to allow a controlled translation in the country of treatment Chapter 4 reports experiences collected during epSOS from relevant stakeholders Furthermore, the possibility of adopting the EMA Article 57 database, created for pharmacovigilance purposes, is studied, starting from the gap analysis between epSOS ePrescription and EMA database contents, performed in openMedicine WP1. Chapter 5 summarises the conclusions and provides some hints as hand over to the following openMedicine work packages. Appendix 1 provides the list of acronyms and definitions... In Appendix 2, details of the epSOS Master Value Sets and EMA Article 57 database value sets are provided. Appendix 3 includes details on the comparison between epSOS ePrescriptions and the EU Guidelines In Appendix 4, the summary report of the epSOS Copenhagen workshop is made available to the public
Sample 1
AutoNDA by SimpleDocs

Related to Goal of D1

  • Appeal of Award Within thirty (30) days of a final award by the single arbitrator, you or we may appeal the award for reconsideration by a three-arbitrator panel. If you or we appeal, the other party may cross- appeal within thirty (30) days afler notice of the appeal. The panel will reconsider all aspects of the initial award that are appealed, including related findings of fact.

  • Referral of Disputes a) Either central party must refer a dispute to the Committee for discussion and review

  • Appeal of Discipline Permanent unit members who are deprived of salary or other loss in compensation or property rights as a result of the imposed discipline may appeal the disciplinary decision under Article XXI, Section 21.3.5, Arbitration, of the Grievance Procedure. Nothing herein shall prevent the parties from mutually agreeing to utilize Step IV, Mediation, of Article XXI, prior to Step V, Arbitration.

  • Denial of Grievance Failure by the School Board or its representative to issue a decision within the time periods provided herein shall constitute a denial of the grievance and the employee may appeal it to the next level.

  • Appeal of Discharge or Discipline Should the discharged or disciplined employee consider the discharge or discipline to be improper, a grievance shall be presented in writing as provided in the grievance procedure. In cases of discharge, or discipline resulting in suspension, the grievance shall be filed at Step 2 of the grievance procedure within 10 days of the discharge.

  • Withdrawal of Consent The Participant understands that the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke the Participant’s consent, the Participant’s employment status or service and career with the Employer will not be adversely affected; the only consequence of the Participant’s refusing or withdrawing the Participant’s consent is that the Company would not be able to grant RSUs or other equity awards to the Participant or administer or maintain such awards. Therefore, the Participant understands that refusing or withdrawing the Participant’s consent may affect the Participant’s ability to participate in the Plan. For more information on the consequences of Participant’s refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact the Participant’s local human resources representative.

  • Approval of Claim When an employee is granted sick leave with pay and Workers’ Compensation leave is subsequently approved for the same period it shall be considered for the purpose of the record of sick leave credits that the employee was not granted sick leave with pay.

  • DENIAL OF ACCESS If rent is not paid within days of the monthly due date, Owner may without notice deny the Occupant access to the property located in the self storage facility. Access will be denied to any party other than the tenant unless said party retains gate code and key to lock on Space or has supplied Owner with written authorization from the tenant to enter the Space. Occupant's access to the facility may also be conditioned in any manner deemed reasonably necessary by Owner to maintain order on the premises. Such measures may include, but are not limited to, restricting hours of operation, requiring verification of occupant's identity and inspecting vehicles that enter the premises. Additionally, if Occupant is renting more than one Space at any given time, default on one rented Space shall constitute default on all rented Spaces, entitling Owner to deny access to Occupant to all rented Spaces.

  • Withdrawal of Licensed Materials The Publisher reserves the right to withdraw from the Licensed Materials any item or part of an item for which it no longer retains the right to publish, or which it has reasonable grounds to believe infringes copyright or is defamatory, obscene, unlawful, or otherwise objectionable. The Distributor shall ensure that the Publisher will give prior written notice of the withdrawal to the Licensee and the Participating Institutions as soon as is practicable, but in no event less than thirty (30) days in advance of such withdrawal, specifying the item or items to be withdrawn.

  • Denial of Liability Executive acknowledges and agrees that neither the payment of the Severance Payment under the Agreement nor this Waiver and Release is to be construed in any way as an admission of any liability whatsoever by the Company or any of the other Released Parties, by whom liability is expressly denied.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!